Consensus report from the Miami liver proton therapy conference

Michael D. Chuong; Adeel Kaiser; Fazal Khan; Parag Parikh; Edgar Ben-Josef; Christopher Crane; Thomas Brunner; Toshiyuki Okumura; Niek Schreuder; Søren M. Bentzen; Alonso Gutierrez; Alejandra Mendez Romero; Sang Min Yoon; Navesh Sharma; Tae Hyun Kim; Kazushi Kishi; Fred Moeslein; Sarah Hoffe; Tracey Schefter; Steven Hanish; Marta Scorsetti; Smith Apisarnthanarax

doi:10.3389/fonc.2019.00457

Consensus report from the Miami liver proton therapy conference

Michael D. Chuong, Adeel Kaiser, Fazal Khan, Parag Parikh, Edgar Ben-Josef, Christopher Crane, Thomas Brunner, Toshiyuki Okumura, Niek Schreuder, Søren M. Bentzen, Alonso Gutierrez, Alejandra Mendez Romero, Sang Min Yoon, Navesh Sharma, Tae Hyun Kim, Kazushi Kishi, Fred Moeslein, Sarah Hoffe, Tracey Schefter, Steven HanishMarta Scorsetti, Smith Apisarnthanarax

Research output: Contribution to journal › Review article

Abstract

An international group of 22 liver cancer experts from 18 institutions met in Miami, Florida to discuss the optimal utilization of proton beam therapy (PBT) for primary and metastatic liver cancer. There was consensus that PBT may be preferred for liver cancer patients expected to have a suboptimal therapeutic ratio from XRT, but that PBT should not be preferred for all patients. Various clinical scenarios demonstrating appropriateness of PBT vs. XRT were reviewed.

Original language	English (US)
Article number	00457
Journal	Frontiers in Oncology
Volume	9
Issue number	MAY
DOIs	https://doi.org/10.3389/fonc.2019.00457
Publication status	Published - Jan 1 2019

Fingerprint

All Science Journal Classification (ASJC) codes

Oncology
Cancer Research

Cite this

Chuong, M. D., Kaiser, A., Khan, F., Parikh, P., Ben-Josef, E., Crane, C., ... Apisarnthanarax, S. (2019). Consensus report from the Miami liver proton therapy conference. Frontiers in Oncology, 9(MAY), [00457]. https://doi.org/10.3389/fonc.2019.00457

Chuong, Michael D. ; Kaiser, Adeel ; Khan, Fazal ; Parikh, Parag ; Ben-Josef, Edgar ; Crane, Christopher ; Brunner, Thomas ; Okumura, Toshiyuki ; Schreuder, Niek ; Bentzen, Søren M. ; Gutierrez, Alonso ; Romero, Alejandra Mendez ; Yoon, Sang Min ; Sharma, Navesh ; Kim, Tae Hyun ; Kishi, Kazushi ; Moeslein, Fred ; Hoffe, Sarah ; Schefter, Tracey ; Hanish, Steven ; Scorsetti, Marta ; Apisarnthanarax, Smith. / Consensus report from the Miami liver proton therapy conference. In: Frontiers in Oncology. 2019 ; Vol. 9, No. MAY.

@article{fac893be23424ebea6bf08803db21385,

title = "Consensus report from the Miami liver proton therapy conference",

abstract = "An international group of 22 liver cancer experts from 18 institutions met in Miami, Florida to discuss the optimal utilization of proton beam therapy (PBT) for primary and metastatic liver cancer. There was consensus that PBT may be preferred for liver cancer patients expected to have a suboptimal therapeutic ratio from XRT, but that PBT should not be preferred for all patients. Various clinical scenarios demonstrating appropriateness of PBT vs. XRT were reviewed.",

author = "Chuong, {Michael D.} and Adeel Kaiser and Fazal Khan and Parag Parikh and Edgar Ben-Josef and Christopher Crane and Thomas Brunner and Toshiyuki Okumura and Niek Schreuder and Bentzen, {S{\o}ren M.} and Alonso Gutierrez and Romero, {Alejandra Mendez} and Yoon, {Sang Min} and Navesh Sharma and Kim, {Tae Hyun} and Kazushi Kishi and Fred Moeslein and Sarah Hoffe and Tracey Schefter and Steven Hanish and Marta Scorsetti and Smith Apisarnthanarax",

year = "2019",

month = "1",

day = "1",

doi = "10.3389/fonc.2019.00457",

language = "English (US)",

volume = "9",

journal = "Frontiers in Oncology",

issn = "2234-943X",

publisher = "Frontiers Media S. A.",

number = "MAY",

}

Chuong, MD, Kaiser, A, Khan, F, Parikh, P, Ben-Josef, E, Crane, C, Brunner, T, Okumura, T, Schreuder, N, Bentzen, SM, Gutierrez, A, Romero, AM, Yoon, SM, Sharma, N, Kim, TH, Kishi, K, Moeslein, F, Hoffe, S, Schefter, T, Hanish, S, Scorsetti, M & Apisarnthanarax, S 2019, 'Consensus report from the Miami liver proton therapy conference', Frontiers in Oncology, vol. 9, no. MAY, 00457. https://doi.org/10.3389/fonc.2019.00457

Consensus report from the Miami liver proton therapy conference. / Chuong, Michael D.; Kaiser, Adeel; Khan, Fazal; Parikh, Parag; Ben-Josef, Edgar; Crane, Christopher; Brunner, Thomas; Okumura, Toshiyuki; Schreuder, Niek; Bentzen, Søren M.; Gutierrez, Alonso; Romero, Alejandra Mendez; Yoon, Sang Min; Sharma, Navesh; Kim, Tae Hyun; Kishi, Kazushi; Moeslein, Fred; Hoffe, Sarah; Schefter, Tracey; Hanish, Steven; Scorsetti, Marta; Apisarnthanarax, Smith.

In: Frontiers in Oncology, Vol. 9, No. MAY, 00457, 01.01.2019.

Research output: Contribution to journal › Review article

TY - JOUR

T1 - Consensus report from the Miami liver proton therapy conference

AU - Chuong, Michael D.

AU - Kaiser, Adeel

AU - Khan, Fazal

AU - Parikh, Parag

AU - Ben-Josef, Edgar

AU - Crane, Christopher

AU - Brunner, Thomas

AU - Okumura, Toshiyuki

AU - Schreuder, Niek

AU - Bentzen, Søren M.

AU - Gutierrez, Alonso

AU - Romero, Alejandra Mendez

AU - Yoon, Sang Min

AU - Sharma, Navesh

AU - Kim, Tae Hyun

AU - Kishi, Kazushi

AU - Moeslein, Fred

AU - Hoffe, Sarah

AU - Schefter, Tracey

AU - Hanish, Steven

AU - Scorsetti, Marta

AU - Apisarnthanarax, Smith

PY - 2019/1/1

Y1 - 2019/1/1

N2 - An international group of 22 liver cancer experts from 18 institutions met in Miami, Florida to discuss the optimal utilization of proton beam therapy (PBT) for primary and metastatic liver cancer. There was consensus that PBT may be preferred for liver cancer patients expected to have a suboptimal therapeutic ratio from XRT, but that PBT should not be preferred for all patients. Various clinical scenarios demonstrating appropriateness of PBT vs. XRT were reviewed.

AB - An international group of 22 liver cancer experts from 18 institutions met in Miami, Florida to discuss the optimal utilization of proton beam therapy (PBT) for primary and metastatic liver cancer. There was consensus that PBT may be preferred for liver cancer patients expected to have a suboptimal therapeutic ratio from XRT, but that PBT should not be preferred for all patients. Various clinical scenarios demonstrating appropriateness of PBT vs. XRT were reviewed.

UR - http://www.scopus.com/inward/record.url?scp=85067651618&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067651618&partnerID=8YFLogxK

U2 - 10.3389/fonc.2019.00457

DO - 10.3389/fonc.2019.00457

M3 - Review article

C2 - 31214502

AN - SCOPUS:85067651618

VL - 9

JO - Frontiers in Oncology

JF - Frontiers in Oncology

SN - 2234-943X

IS - MAY

M1 - 00457

ER -

Access to Document

10.3389/fonc.2019.00457